产品详情
简单介绍：
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-Phospho-Insulin Receptor Beta (Tyr1355)
Cat. Number:
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体KL-3492R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The human insulin receptor is a heterotetrameric membrane glycoprotein consisting of disulfide linked subunits in a beta-alpha-alpha-beta configuration. The beta subunit (95 kDa) possesses a single transmembrane domain, whereas the alpha subunit (135 kDa) is completely extracellular. The insulin receptor exhibits
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体receptor tyrosine kinase (RTK) activity. RTKs are single pass transmembrane receptors that possess intrinsic cytoplasmic enzymatic activity, catalyzing the transfer of the gamma phosphate of ATP to tyrosine residues in protein substrates. RTKs are essential components of signal transduction pathways that affect cell proliferation, differentiation, migration and metabolism.
Included in this large protein family are the insulin receptor and the receptors for growth factors such as epidermal growth factor, fibroblast growth factor and vascular endothelial growth factor. Receptor activation occurs through ligand binding, which facilitates receptor dimerization and autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The interaction of insulin with the alpha subunit of the insulin receptor activates the protein tyrosine kinase of the beta subunit, which then undergoes an autophosphorylation that increases its tyrosine kinase activity. Three adapter proteins, IRS1, IRS2 and Shc, become phosphorylated on tyrosine residues following insulin receptor activation. These three phosphorylated proteins then interact with SH2 domain containing signaling proteins.
Included in this large protein family are the insulin receptor and the receptors for growth factors such as epidermal growth factor, fibroblast growth factor and vascular endothelial growth factor. Receptor activation occurs through ligand binding, which facilitates receptor dimerization and autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The interaction of insulin with the alpha subunit of the insulin receptor activates the protein tyrosine kinase of the beta subunit, which then undergoes an autophosphorylation that increases its tyrosine kinase activity. Three adapter proteins, IRS1, IRS2 and Shc, become phosphorylated on tyrosine residues following insulin receptor activation. These three phosphorylated proteins then interact with SH2 domain containing signaling proteins.
Also known as:
Insulin Receptor (phospho Y1355); Insulin Receptor (phospho Try1355); CD 220; CD220; CD220 antigen; HHF 5; HHF5; HIR B; INSR;
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体INSR; Insulin receptor; Insulin receptor subunit beta; IR; INSR_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human.
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗体
Optimal working dilutions must be determined by the end user.
kl389Mu02 补体成分4a(C4a)多克隆抗体 Polyclonal Antibody to Complement Component 4a (C4a)
kl391Mu02 卵泡抑素(FS)多克隆抗体 Polyclonal Antibody to Follistatin (FS)
kl395Mu02 抑制素A(INHA)多克隆抗体 Polyclonal Antibody to Inhibin A (INHA)
kl396Mu02 性**结合球蛋白(SHBG)多克隆抗体 Polyclonal Antibody to Sex Hormone Binding Globulin (SHBG)
kl397Mu01 转化生长因子β受体Ⅰ(TGFβR1)多克隆抗体 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1)
kl397Mu02 转化生长因子β受体Ⅰ(TGFβR1)多克隆抗体 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1)
kl399Mu02 高迁移率族蛋白1(HMG1)多克隆抗体 Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
kl402Mu02 基质金属蛋白酶12(MMP12)多克隆抗体 Polyclonal Antibody to Matrix Metalloproteinase 12 (MMP12)
kl405Hu01 性别决定区Y框蛋白1(SOX1)多克隆抗体 Polyclonal Antibody to Sex Determining Region Y Box Protein 1 (SOX1)
kl413Mu02 粘蛋白1(MUC1)多克隆抗体 Polyclonal Antibody to Mucin 1 (MUC1)
kl416Mu02 早期生长应答因子1(EGR1)多克隆抗体 Polyclonal Antibody to Early Growth Response Protein 1 (EGR1)
kl417Hu01 鞘磷脂脂质蛋白1(PLP1)多克隆抗体 Polyclonal Antibody to Proteolipid Protein 1, Myelin (PLP1)
kl424Mu02 八聚体结合转录因子4(OCT4)多克隆抗体 Polyclonal Antibody to Octamer Binding Transcription Factor 4 (OCT4)
kl425Mu02 突触素(SYP)多克隆抗体 Polyclonal Antibody to Synaptophysin (SYP)
kl431Mu02 颗粒酶M(GZMM)多克隆抗体 Polyclonal Antibody to Granzyme M (GZMM)
kl433Mu02 蛋白激酶Cδ(PKCδ)多克隆抗体 Polyclonal Antibody to Protein Kinase C Delta (PKCd)
kl437Mu02 雌**受体β(ERβ)多克隆抗体 Polyclonal Antibody to Estrogen Receptor Beta (ERb)
kl438Mu02 促生长**释放**(GHRH)多克隆抗体 Polyclonal Antibody to Growth Hormone Releasing Hormone (GHRH)
kl439Mu02 蛋白激酶Cε(PKCε)多克隆抗体 Polyclonal Antibody to Protein Kinase C Epsilon (PKCe)
